INDIA |NSE |INR
Shares Outstanding | 84.65M | Beta | 1.47 |
---|---|---|---|
Public Float | 20.21M | P/E Ratio | 10.28 |
% Short of Float | - | Dividend (Yield) | - |
Held by Insiders | 71.86% | Ex-Dividend Date | Sep 22, 2021 |
Held by Institutions | - | IPO Date | - |
Mar 21 | Mar 20 | Mar 19 | |
---|---|---|---|
Revenue | INR5.61B | INR4.07B | INR4.62B |
EBITDA | INR1.25B | INR829.00M | INR916.42M |
Net Income | INR625.27M | INR315.74M | INR400.48M |
Total Assets | INR8.12B | INR6.08B | INR5.59B |
Total Cash | INR404.23M | INR95.44M | INR147.98M |
Total Debt | INR2.55B | INR1.57B | INR1.44B |
Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|
Revenue | INR1.21B | INR1.75B | INR1.63B |
EBITDA | INR291.75M | INR481.50M | INR460.88M |
Net Income | INR89.63M | INR230.28M | INR235.63M |
Total Assets | INR | INR8.80B | INR |
Total Cash | INR | INR300.02M | INR |
Total Debt | INR | INR1.31B | INR |
Year | Open | Close | Change |
---|---|---|---|
2021 | INR129.00 | INR152.25 | 18.02% |
2021 | INR119.00 | INR129.00 | 8.40% |
2020 | INR41.70 | INR119.00 | 185.37% |
Date | Open | High | Low | Close | Change | Volume |
---|---|---|---|---|---|---|
Jun 17, 2022 | INR75.95 | INR75.95 | INR68.70 | INR72.20 | -7.79% | 36.10K |
Jun 14, 2022 | INR79.45 | INR80.00 | INR78.00 | INR78.30 | -2.73% | 36.02K |
Jun 9, 2022 | INR81.20 | INR84.75 | INR68.40 | INR80.50 | -2.01% | 76.47K |
Sms pharmaceuticals trades on the NSE stock market in India under the ticker symbol "SMSPHARMA". Sms pharmaceuticals’s stock symbol can also be displayed as "NSE:SMSPHARMA".
Sms pharmaceuticals (NSE:SMSPHARMA) is owned by 0.00% institutional shareholders and by 71.86% insiders. The rest is owned by the public.
Explore More Details on Sms pharmaceuticals's “Ownership” Section
Sms pharmaceuticals's key executive team includes the following managers:
Sms pharmaceuticals (NSE:SMSPHARMA) is classified under the "Healthcare" sector and under the "Drug Manufacturers-General" industry.
Currently the number of employees working for Sms pharmaceuticals is 1,080.
Sms pharmaceuticals (NSE:SMSPHARMA) is headquartered in India.
Sms pharmaceuticals’s mailing address is Plot No. 72, Hyderabad, India, 500034.
The company’s phone number is 91 40 2525 9999.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.